# Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis

> **NCT01166646** · PHASE2 · COMPLETED · sponsor: **Therapeutics, Inc.** · enrollment: 43 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** Halobetasol Proprionate Lotion 0.05%
- **DRUG:** Halobetasol Proprionate Cream 0.05%

## Key facts

- **NCT ID:** NCT01166646
- **Lead sponsor:** Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2016-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01166646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01166646, "Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01166646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*